Michael Philbin Email & Phone Number

Winter Garden, Fl, Us

Director, Value Evidence and Outcomes Strategic Initiatives - Payer Engagement TeamFacilitated the design, execution, and evaluation of key initiatives that optimize product value for US managed care payers, healthcare customers and population health decision makers 90% increase of proactive Payer Focused Field Medical Team’s external resources  Austedo XR Utilization Management Criteria Initiative “Operation PA Enhancement”o Eliminated at least 35 different Medicare Part D, FFS and MM Austedo/Austedo XR Payer restrictive clinical Utilization Management Criteria’s Field Medical Affairs IDN Centric coordinated engagement strategy with the targeted IDNs, hospitals and Community Mental Health Centers 2023 Payer Advisory Board with National and Regional Payer Senior Leadership Above brand initiatives on Social Determinates of Health and NCQA and Joint Commission related Quality MeasuresGeneration of data and evidence required for validation of the company’s pharmaceutical innovations’ relative medical value and plans for strategic market access.  Co-developed the Tardive Dyskinesia Under Estimator App o Geographic region and IDed of Social Determinants of Health within the USA Authored over twelve posters and more than two publications

Parsippany, New Jersey

 Led the eight-member field Medical Outcomes Liaison Team’s implementation of medical and business segment strategies to underscore US Medical Affairs and US Managed Market combined goals.  Drove medical value and clinical differentiation; build the target product profile; deliver launch excellence throughout the portfolio lifecycle.

• Serve as a medical and scientific resource for the Managed Care, Payor, and Health System Delivery Network community in therapeutic areas of interest to Teva Pharmaceuticals USA.• Act as a resource and support the Market Access team communicating the value proposition of Teva Products within corporate guidelines.• Engage in scientific and clinical dialogue with key individuals in the Managed Care system and outcomes research area regarding the value proposition for Teva products and explore appropriate collaborative research opportunities.• Act as a field resource and support the HEOR team helping to inform the strategic plan for the value proposition of Teva Products and execution of individual projects aligned to the strategic plan of Teva Products.

Presented/discussed balanced clinical and HEOR topics during national/regional managed care organizations (MCOs) and pharmacy benefit management (PBMs) meetings to support the appropriate use of Mallinckrodt therapieso Humana, Horizon, Wellcare, Optima, Cigna, MC 21 (PR), CVS Caremark, Harvard Pilgrim, HMSA, Federal BCBS… Cross therapeutic responsibility in immunology, rheumatology, neurology, nephrology, therapeutic delivery devices, neonatology pain management and pulmonologyIdentify and execute partnership opportunities with external customers in managed markets including health plans, PBMs, specialty pharmacies and health systemsConceptualization, development and implementation of HEOR outcomes studies across a broad range of autoimmune diseases leading to the presentations/submissions of abstracts, posters and publications to national medical conferences and medical/health outcomes journalso Multiple Sclerosis, Rheumatoid Arthritis, Infantile Spasms, Lupus, Nephrotic Syndrome… Development of budget impact models, AMCP dossiers, commercial value proposition decks and model policies in collaboration with the market access team

Orlando, Florida Area

Abbott Laboratories/AbbVie Global Medical Affairs 2002 - 2014Health Economic Outcomes Research (HEOR) Presented and led roundtable discussions with managed care organizations on disease states and HEORAvMed, Florida Medicaid, Blue Cross Blue Shield of Florida, United Health Care,Triple-S Salud, Humana and Consorcio Region Sur De Puerto RicoH-CUP.net (U.S. Department of Health and Human Services) Database analysis on CABG procedures from 1993 to 2010Working Group Member of the Atrasentan/ABT-719/Bardoxolone/Zemplar Global HEOR Sub TeamsUrine Albumin Creatinine Ratio (UACR) Testing and Treatment Study ProtocolGlobal Medical AffairsDeveloped and maintained 50 + professional relationships with key opinion leaders (cardiologists, critical care, endocrinologists, internists, nephrologists, surgeons, basic scientists and allied HCPs) to conduct round table scientific/HEOR discussionsPartnered with Global Medical Affairs and Research and Development on phase 2 and phase 3 clinical studies in addition to Investigator Initiated Studies (IIS) RADAR, SONAR, ABT-719, Bardoxolone, IMPACT, PRIMO 1 and 2, VITAL and more than 25 Investigator Initiated StudiesInterim with Abbott Medical Affairs, Spain reporting to Angel Ramirez Burgos, MD PhD Collaborated with international physicians on slide development of key lectures and posters presented at World Congress of NephrologyPartnered with University of Miami, Division of Nephrology on a two day International Scientific Conference for physicians from Central and South America Advocacy and Government RelationsPresented, in collaboration with LANKF, before the State of Louisiana, Department of Health and Hospitals about cost savings associated with early identification and intervention of patients with chronic kidney disease, LANKF awarded $250,000 Collaborated with advocacy organizations in passing of the Alonzo Mourning Bill by state legislature and signed by Governor Charlie Crist

Global Pharmaceutical Rd

Health Economic Outcomes Research (HEOR) Presented and led roundtable discussions with managed care organizations on disease states and HEORAvMed, Florida Medicaid, Blue Cross Blue Shield of Florida, United Health Care,Triple-S Salud, Humana and Consorcio Region Sur De Puerto RicoH-CUP.net (U.S. Department of Health and Human Services) Database analysis on CABG procedures from 1993 to 2010Working Group Member of the Atrasentan/ABT-719/Bardoxolone/Zemplar Global HEOR Sub TeamsUrine Albumin Creatinine Ratio (UACR) Testing and Treatment Study ProtocolGlobal Medical AffairsDeveloped and maintained 50 + professional relationships with key opinion leaders (cardiologists, critical care, endocrinologists, internists, nephrologists, surgeons, basic scientists and allied HCPs) to conduct round table scientific/HEOR discussionsPartnered with Global Medical Affairs and Research and Development on phase 2 and phase 3 clinical studies in addition to Investigator Initiated Studies (IIS) RADAR, SONAR, ABT-719, Bardoxolone, IMPACT, PRIMO 1 and 2, VITAL and more than 25 Investigator Initiated StudiesInterim with Abbott Medical Affairs, Spain reporting to Angel Ramirez Burgos, MD PhD Collaborated with international physicians on slide development of key lectures and posters presented at World Congress of NephrologyPartnered with University of Miami, Division of Nephrology on a two day International Scientific Conference for physicians from Central and South America Advocacy and Government RelationsPresented, in collaboration with LANKF, before the State of Louisiana, Department of Health and Hospitals about cost savings associated with early identification and intervention of patients with chronic kidney disease, LANKF awarded $250,000 Collaborated with advocacy organizations in passing of the Alonzo Mourning Bill by state legislature and signed by Governor Charlie Crist

Orlando, Florida Area

Development of policy and procedures for hospital based pharmacy servicesManagement and training of a staff of 12 within the Ambulatory Care Clinics at the Orlando Regional Medical Center  Creation of Pharmacist led clinical programsPost Myocardial Infarction (MI) Program, dyslipidemia testing/education, bone density evaluationsAsthma training and monitoring and Smoke Cessation ClinicCreated the HIV/HCV Medication Management Clinic, Sample Medication Program, Discharge Counseling Services

Orlando, Florida Area

Development of policy and procedure for Pharmacy ServicesDevelopment, recruitment and management of staff for Ambulatory and Outpatient Pharmacies at Orlando Regional Health SystemStaff pharmacist adult and pediatric oncology servicesCreated the HIV/HCV Medication Management Clinic, Sample Medication Program, Discharge Counseling Services, Asthma and Smoke Cessation ClinicsCreation of Pharmacist led Clinical ProgramsPost Myocardial Infarction (MI) program, bone density, dyslipidemia testing/education, Diabetic equipment education, asthma training and monitoring

Master'S Degree, Pharmacoeconomics/Pharmaceutical Economics

Master Of Business Administration (M.B.A.), International Business

Activities and Societies: International Business Practicum to Brazil 2000

Doctor Of Pharmacy

Activities and Societies: Student Government